Cha DR - Search Results

1

Yoon SG, Ghee JY, Yoo JA, Park BY, Cha JJ, Kang YS, Han SY, Min HS, Lee JE, Han JY, Cha DR. Yoon SG, et al. Among authors: cha jj, cha dr. Gerontology. 2023;69(7):852-865. doi: 10.1159/000529392. Epub 2023 Jan 28. Gerontology. 2023. PMID: 36709751 Free article.

2

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. Cha DR, et al. J Endocrinol. 2004 Oct;183(1):183-94. doi: 10.1677/joe.1.05647. J Endocrinol. 2004. PMID: 15525586

3

Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.

Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH. Cha DR, et al. Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x. Diabet Med. 2005. PMID: 15606685

4

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Kim NH, et al. Among authors: cha dr. Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x. Kidney Int. 2005. PMID: 15610240 Free article.

5

Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population.

Kang YS, Han KH, Han SY, Kim HK, Cha DR. Kang YS, et al. Among authors: cha dr. Clin Nephrol. 2005 Apr;63(4):258-66. doi: 10.5414/cnp63258. Clin Nephrol. 2005. PMID: 15847252

6

Role of aldosterone in diabetic nephropathy.

Cha DR, Kang YS, Han SY, Jee YH, Han KH, Kim HK, Han JY, Kim YS. Cha DR, et al. Nephrology (Carlton). 2005 Oct;10 Suppl:S37-9. doi: 10.1111/j.1440-1797.2005.00455.x. Nephrology (Carlton). 2005. PMID: 16174286

7

High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes.

Han SY, Kang YS, Jee YH, Han KH, Cha DR, Kang SW, Han DS. Han SY, et al. Among authors: cha dr. Cell Tissue Res. 2006 Feb;323(2):321-32. doi: 10.1007/s00441-005-0065-4. Epub 2005 Sep 28. Cell Tissue Res. 2006. PMID: 16189717

8

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

Kang YS, Park YG, Kim BK, Han SY, Jee YH, Han KH, Lee MH, Song HK, Cha DR, Kang SW, Han DS. Kang YS, et al. Among authors: cha dr. J Mol Endocrinol. 2006 Apr;36(2):377-88. doi: 10.1677/jme.1.02033. J Mol Endocrinol. 2006. PMID: 16595708 Free article.

9

Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.

Han KH, Kang YS, Han SY, Jee YH, Lee MH, Han JY, Kim HK, Kim YS, Cha DR. Han KH, et al. Among authors: cha dr. Kidney Int. 2006 Jul;70(1):111-20. doi: 10.1038/sj.ki.5000438. Epub 2006 May 24. Kidney Int. 2006. PMID: 16723984 Free article.

10

An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.

Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR. Han SY, et al. Among authors: cha dr. Nephrol Dial Transplant. 2006 Sep;21(9):2406-16. doi: 10.1093/ndt/gfl238. Epub 2006 May 25. Nephrol Dial Transplant. 2006. PMID: 16728425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page